Literature DB >> 29336052

Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.

Paurush Ambesh1, Kaveh Zivari1, Chukwudi Obiagwu2, Vijay Shetty2, Stephan Kamholz1, Gerald Hollander2, Jacob Shani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29336052      PMCID： PMC5867151          DOI： 10.1111/bcp.13509

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

1.  Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil.

Authors:  E Van Cutsem; P M Hoff; J L Blum; M Abt; B Osterwalder
Journal:  Ann Oncol       Date:  2002-03       Impact factor: 32.976

Review 2.  The prodrugs of 5-fluorouracil.

Authors:  M Malet-Martino; P Jolimaitre; R Martino
Journal:  Curr Med Chem Anticancer Agents       Date:  2002-03

3.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.

Authors:  M Mosseri; H J Fingert; L Varticovski; S Chokshi; J M Isner
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

6.  5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.

Authors:  B Patel; R A Kloner; J Ensley; M Al-Sarraf; J Kish; J Wynne
Journal:  Am J Med Sci       Date:  1987-10       Impact factor: 2.378

7.  5-fluorouracil-induced coronary vasospasm.

Authors:  Laura K Shoemaker; Umesh Arora; Caio M Rocha Lima
Journal:  Cancer Control       Date:  2004 Jan-Feb       Impact factor: 3.302

8.  Capecitabine may induce coronary artery vasospasm.

Authors:  Eleutherios Tsiamis; Andreas Synetos; Christodoulos Stefanadis
Journal:  Hellenic J Cardiol       Date:  2012 Jul-Aug

9.  5-Fluorouracil induces arterial vasocontractions.

Authors:  T Südhoff; M-D Enderle; M Pahlke; C Petz; C Teschendorf; U Graeven; W Schmiegel
Journal:  Ann Oncol       Date:  2004-04       Impact factor: 32.976

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971
View more
  2 in total

1.  Rapidly developing heart failure from capecitabine cardiotoxicity: a case study.

Authors:  Paurush Ambesh; Kaveh Zivari; Chukwudi Obiagwu; Vijay Shetty; Stephan Kamholz; Gerald Hollander; Jacob Shani
Journal:  Br J Clin Pharmacol       Date:  2018-02-09       Impact factor: 4.335

2.  Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase.

Authors:  Justine Perino; Nathan Mottal; Yohann Bohbot; Vincent Servant; Aude Berroneau; Pierre Poustis; Pierre Fenaux; Kamel Laribi; Aude Charbonnier; Emilien Bilion; Claire Calmettes; Bernard Bégaud; Arnaud Pigneux; Noël Milpied; Ghada Miremont-Salamé; Hélène Théophile; Sophie Dimicoli-Salazar
Journal:  Br J Clin Pharmacol       Date:  2020-02-03       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.